Venus Remedies, has received grant of a european patent for its drug ACHNIL which is a once a day injection formulation for pain killer. ACHNIL contains Aceclefenac as active drug which is a non steroidal, anti-inflammatory drug and used to releive acute and chronic pain and swelling in rheumatoid arthritis, osteoarthritis, low back pain, spondylitis, dental pain, post traumatic pain etc. This injection is for 24 hr relief from pain.
Company planning to commercialize ACHNIL through out-licencing to european pharma companies. ACHNIL has already approved by the DCGI (Drug controller general of india).
Company planning to commercialize ACHNIL through out-licencing to european pharma companies. ACHNIL has already approved by the DCGI (Drug controller general of india).
No comments:
Post a Comment